"This measure assesses the percentage of adult diabetes patients aged 18-75 years who received any test for microalbuminuria."
Why is this important?: "Diabetes is the leading cause of end-stage renal disease (ESRD). In the United States, diabetic nephropathy accounts for about one-third of all cases of ESRD. The earliest clinical evidence of nephropathy is the appearance of low, but abnormal levels of albumin (protein) in the urine, referred to as microalbuminuria. Early detection and treatment may prevent or slow the progression of diabetic nephropathy.
American Association of Clinical Endocrinologists/American College of Endocrinology (AACE/ACE) recommends that the initial assessment should include a urinalysis, test for microalbuminuria and creatinine clearance. The renal complication module should be performed annually and includes a test for microalbuminuria and creatinine clearance.
American Diabetes Association (ADA) recommends that a routine urinalysis be performed at diagnosis in patients with type 2 diabetes. If the urinalysis is positive for protein, a quantitative measure is frequently helpful in the development of a treatment plan. If the urinalysis is negative for protein, a test of the presence of microalbumin is necessary."
Taken from the National Quality Measures Clearinghouse